ABBVIE INC. vs. Prelude Therapeutics Incorporated
ABBVIE INC. and Prelude Therapeutics Incorporated are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABBV | PRLD | |
|---|---|---|
| Market Cap | $465.26 billion | $388.64 million |
| Revenue (TTM) | — | $22.42 million |
| Net Income (TTM) | — | $-60,488,000 |
ABBV leads on 1 of 1 size & scale factors.
Valuation
| ABBV | PRLD | |
|---|---|---|
| Price / Book | — | 2.91 |
| Price / Sales | — | 17.33 |
ABBV and PRLD split the valuation factors evenly.
Profitability
| ABBV | PRLD | |
|---|---|---|
| Net Margin | — | -269.75% |
| Return on Equity | — | -45.23% |
ABBV and PRLD split the profitability factors evenly.
Dividend
| ABBV | PRLD | |
|---|---|---|
| Dividend Yield | 2.65% | — |
ABBV and PRLD split the dividend factors evenly.
Risk & Sentiment
| ABBV | PRLD | |
|---|---|---|
| Short Interest | 0.85% | 0.01% |
PRLD leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, PRLD overview, PRLD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.